シロスタゾールを投与した洞不全症候群Rubenstein II型の犬の1例

書誌事項

タイトル別名
  • A Canine Case of Sick Sinus Syndorome (Rubenstein-II) Successfully Treated with Cilostazol: Findings on Monitoring with Holter Electrocardiography
  • 症例報告 シロスタゾールを投与した洞不全症候群Rubenstein Ⅱ型の犬の1例 : 投与前後におけるホルター心電図検査所見
  • ショウレイ ホウコク シロスタゾール オ トウヨ シタ ホラ フゼン ショウコウグン Rubenstein Ⅱ カタ ノ イヌ ノ 1レイ : トウヨ ゼンゴ ニ オケル ホルター シンデンズ ケンサ ショケン
  • —投与前後におけるホルター心電図検査所見—

この論文をさがす

説明

A 13-years-old female Shiba-breed dog was seen because of syncope and wobbling motion. A monitoring scalar electrocardiography showed high frequency sinus arrests and atropine test was positive. Oral atropine sulfate had been administered for the treatment. Afterwards, the clinical sign had disappeared. On the 378th day, syncope relapsed again and atropine test became negative. Based on the results of electrocardiography and atropine test, Sick Sinus Syndrome was strongly suspected. Administration of cilostazol, which is a phosphodiesterase inhibitor, and enalapril maleate resulted in an immediate disappearance of the clinical signs again. Monitoring holter electrocardiography was conducted before and after the treatment. The cilostazol therapy couldn't increase the total daily heat-beat counts. However, frequency of sinus arrest that exceeds 6 seconds decreased, and the maximal period of sinus arrest was favorably shortened.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ